Breaking News Instant updates and real-time market news.

RARX

RA Pharmaceuticals

$13.29

-0.12 (-0.89%)

06:55
11/21/16
11/21
06:55
11/21/16
06:55

RA Pharmaceuticals initiated with a Buy at SunTrust

SunTrust analyst Yatin Suneja started RA Pharmaceuticals with a Buy rating and $32 price target.

RARX RA Pharmaceuticals
$13.29

-0.12 (-0.89%)

11/21/16
JEFF
11/21/16
INITIATION
Target $25
JEFF
Buy
RA Pharmaceuticals initiated with a Buy at Jefferies
Jefferies analyst Eun Yang started RA Pharmaceuticals with a Buy rating and $25 price target. The analyst sees greater than 100% potential upside should the Phase II data for RA101495 in paroxysmal nocturnal hemoglobinuria patients be positive in the second half of 2017.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.